Samir Kapadia
@tavrkapadia
Followers
4K
Following
2K
Media
4
Statuses
929
@ClevelandClinic Department Chairman, Cardiovascular Medicine | @CleClinicHVTI @CCFcards | opinions are my own
Cleveland, OH
Joined January 2016
Thanks to all who joined us today, for an engaging symposium in Columbus, OH! Looking forward to Advances in Cardiovascular Care 2026🫀
Join us next week for Advancing Cardiovascular Care 2025 in Columbus, OH! @ClevelandClinic will review advances in the prevention, diagnosis & management of CVD — including new technologies & therapeutic options available to clinicians. Link to register: https://t.co/iZTGhDyUjd
0
7
30
Registered for Mastering the Management of Aortic Valve Disease 2025 yet? @LarsSvenssonMD explains why you should join @ClevelandClinic Dec 5 & 6 in New York City. Learn more & register: https://t.co/15iwWqVfZp
5
3
20
Could we soon lower cholesterol for life with just one treatment? Results from our Phase 1 clinical trial found a gene editing therapy safely reduced "bad" cholesterol in people with lipid disorders resistant to current medications. #AHA25 Read more: https://t.co/3W5eUyTu66
0
6
15
Looking forward to an engaging course and many discussions on aortic valve disease next month in NYC. @CleClinicHVTI #AortaEd
Join us for Mastering the Management of Aortic Valve Disease in NYC Dec 5-6🫀 Faculty will explore the latest innovations, evidence-based practices, procedural techniques & strategies critical for managing aortic valve disease. Learn more & register: https://t.co/yMlHpvNkkV
1
5
19
Timing of transcatheter aortic valve replacement after balloon aortic valvuloplasty: Insights from a multicenter real-world cohort @tavrkapadia @ClevelandClinic
https://t.co/R08uqIKypM
0
5
17
Excited to share our case now out in @JACCJournals Simultaneous closure of a left ventricular pseudoaneurysm and mitral valve perforation using AVP II Grateful to all co-authors and mentors Dr. @SergeHarbMD & Dr. @tavrkapadia
https://t.co/DSftiXJhUW
5
9
54
Check out our most recent publication in @PCVDJournal on the timing of TAVR after BAV. Across a multicenter real-world cohort, TAVR >30 days post-BAV was associated with fewer adverse events than earlier intervention.
Timing of transcatheter aortic valve replacement after balloon aortic valvuloplasty: Insights from a multicenter real-world cohort @tavrkapadia @ClevelandClinic
https://t.co/R08uqIKypM
6
3
33
Join us next week for Advancing Cardiovascular Care 2025 in Columbus, OH! @ClevelandClinic will review advances in the prevention, diagnosis & management of CVD — including new technologies & therapeutic options available to clinicians. Link to register: https://t.co/iZTGhDyUjd
0
5
16
We were honored to host Dr. Rasha Al-Lamee @rallamee for today’s noon conference: an incredibly insightful discussion on her career in cardiology and the landmark ORBITA trials! @venumenon10 @tavrkapadia @CleClinicHVTI
0
9
92
Join us for Mastering the Management of Aortic Valve Disease in NYC Dec 5-6🫀 Faculty will explore the latest innovations, evidence-based practices, procedural techniques & strategies critical for managing aortic valve disease. Learn more & register: https://t.co/yMlHpvNkkV
0
3
19
Tracking the long-term safety of performing SAVR, other heart surgeries after #TAVR @tavrkapadia @ClevelandClinic #cardiology
cardiovascularbusiness.com
More and more TAVR patients are going to require SAVR later in life. A research team out of Cleveland Clinic hoped to learn more about how this one-two combination may impact long-term outcomes.
0
2
4
High blood pressure affects millions, and a new drug may offer hope. @ljlaffin recaps results from a recent trial that could impact future care for hypertension, in this week's #LoveYourHeart podcast from @ClevelandClinic. Full podcast: https://t.co/ogvo3HW0s2
0
6
25
Listen to the new #LoveYourHeart podcast as @DrDamluji & @InnovateGeriCCF discuss aging, heart health & holistic care strategies to improve outcomes & quality of life🫀 Full podcast: https://t.co/qw2QJkp09A
0
3
17
When it comes to predicting outcomes post-TAVR, Do you trust the loud Mean Gradient 📢or the sneaky introvert AT/ET ratio 🤫⏱️? One of them isn’t who they claim to be 🕵️Check our 📰 from @CleClinicHVTI 🫀under @tavrkapadia @JACCJournals by ⭐️@tamarilomaia
https://t.co/EXHMJoJDdB
0
2
15
In two consecutive @JACCJournals papers, we systematically describe the characteristics of hemorrhagic ST-segment elevation myocardial infarction patients in the U.S., and the cardioprotective role of collateral circulation in intramyocardial hemorrhage. #JACCAdv @CandiceSilvers1
3
20
64
Extremely happy to share that our original research manuscript on the significance of post-TAVR AT/ET ratio has been published in @JACCJournals Grateful to my mentor @tavrkapadia for everything! https://t.co/vYlGhMNESe
jacc.org
3
2
9
Type 2 MI now accounts for over 25% of all MIs, with lower short-term but higher long-term mortality than type 1 MI @DesaiMilindY
@JJheart_doc @tavrkapadia @UTSWheart @ziadak @amgadmentias @LannyHallMD @NeilKeshvani @ambarish4786 #AHAJournals
https://t.co/ZdERijQwBM
0
6
19
We are enhancing our heart care for older adults with the opening of a Cardiovascular Center on Aging. It will integrate care from geriatric and cardiac specialists to address the unique needs of those over 65. https://t.co/fy6uM4Gkpy
newsroom.clevelandclinic.org
Cardiovascular Center on Aging integrates heart care with geriatric expertise
0
4
13
It’s not too late to register for #Cardiovascular Update 2025🫀 Join @ClevelandClinic & @ABCardio1 Oct 16 & 17 to learn about the latest science & best-practices to improve the prevention, management & outcomes for individuals with — or at risk for CVD. https://t.co/Ko1gBQLh0J
0
4
14
Mitral Annular Function significantly contributes to LVSV. In @JACCJournals we validated #CCT assessment of #MAF and assessed its contribution to LVSV in various degrees of #MAC, #FMR and #PMR. TMVR/TEER implications below 👇🏻 @tavrkapadia @SergeHarbMD
https://t.co/UxL30LSZgG
1
2
19